Effects of nonsurgical periodontal therapy on C-reactive protein and serum lipids in Jordanian adults with advanced periodontitis

Journal of Periodontal Research

Volumn 46, Issue 5, 2011, Pages 616-621

  Kamil, W ^a   Al Habashneh, R ^a   Khader, Y ^a   Al Bayati, L ^b   Taani, D ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^b Private Practice   (Jordan)

Author keywords

C reactive protein; Clinical attachment level; Lipids; Nonsurgical periodontal therapy; Periodontal disease

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD; CHRONIC PERIODONTITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PERIODONTAL POCKET; PERIODONTICS; PREVENTIVE DENTISTRY; RANDOMIZED CONTROLLED TRIAL; TOOTH PLAQUE;

ADULT; C-REACTIVE PROTEIN; CHOLESTEROL; CHRONIC PERIODONTITIS; DENTAL PLAQUE INDEX; DENTAL SCALING; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIODONTAL INDEX; PERIODONTAL POCKET; TRIGLYCERIDES;

EID: 80051905951     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2011.01380.x     Document Type: Article

References (37)

1. Tonetti MS. Periodontitis and risk for atherosclerosis: an update on intervention trials. J Clin Periodontol 2009;36(Suppl 10):15-19.
2. Persson GR, Persson RE. Cardiovascular disease and periodontitis: an update on the associations and risk. J Clin Periodontol 2008;35:362-379.
3. Mustapha IZ, Debrey S, Oladubu M, Ugarte R. Markers of systemic bacterial exposure in periodontal disease and cardiovascular disease risk: a systematic review and meta-analysis. J Periodont 2007;78:2289-2302.
4. Slade GD, Ghezzi EM, Heiss G, Beck JD, Riche E, Offenbacher S. Relationship between periodontal disease and C-reactive protein among adults in the Atherosclerosis Risk in Communities study. Arch Intern Med 2003;163:1172-1179.
5. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98:731-733.
6. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363.
7. Ebersole JL, Machen RL, Steffen MJ, Willmann DE. Systemic acute-phase reactants, C-reactive protein and haptoglobin, in adult periodontitis. Clin Exp Immunol 1997;107:347-352.
8. Loos BG, Craandijk J, Hoek FJ, Wertheim-van Dillen PM, van der Velden U. Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodont 2000;71:1528-1534.
9. Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodont 2001;72:1221-1227.
10. Dye BA, Choudhary K, Shea S, Papapanou PN. Serum antibodies to periodontal pathogens and markers of systemic inflammation. J Clin Periodontol 2005;32:1189-1199.
11. Salzberg TN, Overstreet BT, Rogers JD, Califano JV, Best AM, Schenkein HA. C-reactive protein levels in patients with aggressive periodontitis. J Periodont 2006;77:933-939.
12. Sun XJ, Meng HX, Shi D et al. Elevation of C-reactive protein and interleukin-6 in plasma of patients with aggressive periodontitis. J Periodont Res 2009;44:311-316.
13. Craig RG, Yip JK, So MK, Boylan RJ, Socransky SS, Haffajee AD. Relationship of destructive periodontal disease to the acute-phase response. J Periodont 2003;74:1007-1016.
14. Genco RJ. Host responses in periodontal diseases: current concepts. J Periodont 1992;63:335-355.
15. Fredriksson MI, Mattila K, Vesanen M et al. Effect of treating periodontitis on C-reactive protein levels: a pilot study. BMC Infect Dis 2002;2:30-33.
16. Iwamoto Y, Nishimura F, Soga Y et al. Antimicrobial periodontal treatment decreases serum C-reactive protein, tumor necrosis factor-alpha, but not adiponectin levels in patients with chronic periodontitis. J Periodont 2003;74:1231-1236.
17. Mattila K, Vesanen M, Valtonen V et al. Effect of treating periodontitis on C-reactive protein levels: a pilot study. BMC Infect Dis 2002;2:30-33.
18. D'Aiuto F, Parkar M, Andreou G, Brett PM, Ready D, Tonetti MS. Periodontitis and atherogenesis: causal association or simple coincidence? J Clin Periodontol 2004;31:402-411.
19. Taylor BA, Tofler GH, Carey HMR et al. Full-mouth tooth extraction lowers systemic inflammatory and thrombotic markers of cardiovascular risk. J Dent Res 2006;85(1):74-78.
20. Ide M, McPartlin D, Coward PY, Crook M, Lumb P, Wilson RF. Effect of treatment of chronic periodontitis on levels of serum markers of acute-phase inflammatory and vascular responses. J Clin Periodontol 2003;30:334-340.
21. Paraskevas S, Huizinga JD, Loos BG. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 2008;35:277-290.
22. Brown LJ, Loe H. Prevalence, extent, severity and progression of periodontal disease. Periodontol 2000 1993;2:57-71.
23. WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva, 1998.
24. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
25. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
26. Löe H, Silness J. Periodontal disease in pregnancy. 1. Prevalence and severity. Acta Odontol Scand 1963;21:533-551.
27. Pitiphat W, Savetsilp W, Wara-Aswapati N. C-reactive protein associated with periodontitis in a Thai population. J Clin Periodontol 2008;35:120-125.
28. D'Aiuto F, Parkar M, Nibali L, Suvan J, Lessem J, Tonetti MS. Periodontal infections cause changes in traditional and novel cardiovascular risk factors: results from a randomized controlled clinical trial. Am Heart J 2006;151:977-984.
29. Ioannidou E, Malekzadeh T, Dongari-Bagtzoglou A. Effect of periodontal treatment on serum C-reactive protein levels: a systematic review and meta-analysis. J Periodont 2006;77:1635-1642.
30. Yamazaki K, Honda T, Oda T et al. Effect of periodontal treatment on the C-reactive protein and proinflammatory cytokine levels in Japanese periodontitis patients. J Periodont Res 2005;40:53-58.
31. Marcaccini AM, Meschiari CA, Sorgi CA et al. Circulating interleukin-6 and high-sensitivity C-reactive protein decrease after periodontal therapy in otherwise healthy subjects. J Periodont 2009;80:594-602.
32. D'Aiuto F, Parkar M, Andreou G et al. Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 2004;83:156-160.
33. Elter JR, Hinderliter AL, Offenbacher S et al. The effects of periodontal therapy on vascular endothelial function: a pilot trial. Am Heart J 2006;151:47.
34. Tüter G, Kurtiş B, Serdar M et al. Effects of scaling and root planing and sub-antimicrobial dose doxycycline on oral and systemic biomarkers of disease in patients with both chronic periodontitis and coronary artery disease. J Clin Periodontol 2007;34:673-681.
35. Ushida Y, Koshy G, Kawashima Y et al. Changes in serum interleukin-6, C-reactive protein and thrombomodulin levels under periodontal ultrasonic debridement. J Clin Periodontol 2008;35:969-975.
36. Offenbacher S, Beck JD, Moss K et al. Results from the Periodontitis and Vascular Events (PAVE) Study: a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. J Periodont 2009;80:190-201.
37. D'Aiuto F, Nibali L, Parkar M, Suvan J, Tonetti MS. Contribution of periodontal therapy on individual cardiovascular risk assessment. J Dent Res 2005;84:269-273.